Related Experiment Video

Updated: Apr 22, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

20.3K

[Diabetes mellitus and pancreatic cancer - cause or result?]

Alena Smahelová

    Vnitrni Lekarstvi
    |October 9, 2014
    PubMed

    Insights

    Glucagon-like peptide-1 receptor agonists are effective new treatments for type 2 diabetes, offering significant blood sugar reduction. These incretin mimetics also positively impact weight and hypertension, with both short-acting and long-acting options available.

    Area of Science:

    • Pharmacology and Endocrinology
    • Metabolic Diseases

    Context:

    • Type 2 diabetes mellitus management
    • Emerging therapeutic agents

    Purpose:

    • To describe the pathophysiology, pharmacology, and clinical applications of glucagon-like peptide-1 receptor agonists.
    • To highlight the antihyperglycemic effects and additional benefits of these agents.

    Summary:

    • Glucagon-like peptide-1 (GLP-1) receptor agonists, or incretin mimetics, are novel drugs for type 2 diabetes with substantial antihyperglycemic efficacy.
    • Available as short-acting and long-acting formulations, they influence glucose levels, body weight, and hypertension.
    • The review details their pathophysiological mechanisms, pharmacological distinctions, and clinical utility.

    Impact:

    • Provides a comprehensive overview for clinicians and researchers on GLP-1 receptor agonists.
    • Informs treatment strategies for type 2 diabetes, considering broader patient factors beyond glycemic control.
    • Highlights the therapeutic potential of incretin mimetics in managing metabolic complications.

    More Related Videos

    Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

    Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

    Published on: February 2, 2024

    1.6K
    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

    Published on: November 19, 2019

    13.2K

    Related Concept Videos

    Psychoneuroimmunology: Diabetes and Cancer01:19

    Psychoneuroimmunology: Diabetes and Cancer

    Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
    520
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
    3.9K
    Carbohydrate Metabolism01:36

    Carbohydrate Metabolism

    Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
    Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
    10.4K
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    4.8K
    Type II Diabetes II: Pathophysiology01:24

    Type II Diabetes II: Pathophysiology

    PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
    6
    Type I Diabetes II: Pathophysiology01:26

    Type I Diabetes II: Pathophysiology

    Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
    23